Health Sector Transformation Program – The Milli Chronicle

Saturday, October 25, 2025

Latest:

Cisco Saudi Arabia Drives Innovation and Strengthens Cybersecurity with AI-Powered Solutions
OIC Conference Highlights Strengthened Collaboration for Water Management Across Member States
Saudi Crown Prince Extends Condolences to Kuwait on Passing of Esteemed Sheikh Ali
Zenos Health Summit Debuts in Diriyah, Showcasing Saudi Arabia’s Leadership in Wellness and Longevity
IBM and AMD bring quantum power to reality

Factual Version of a Story

Latest Middle East and North Africa News

NewsDesk Milli Chronicle October 24, 2025 biohacking summit, Diriyah wellness event, Health Sector Transformation Program, holistic health Saudi Arabia, integrative medicine Saudi Arabia, longevity experts Saudi Arabia, Mazen and Marwan Karnaby, medtech and biotech opportunities, performance wellness, personalized wellness, preventive health, Quality of Life Program Saudi, Saudi health innovation, Saudi longevity programs, Saudi wellness initiatives, Zenos Health Summit

Zenos Health Summit Debuts in Diriyah, Showcasing Saudi Arabia’s Leadership in Wellness and Longevity

Diriyah – The first Zenos Health Summit kicked off this week in historic Diriyah, marking a milestone for the Kingdom’s

Latest Middle East and North Africa News

NewsDesk Milli Chronicle October 9, 2025October 9, 2025 advanced medical treatment, ALS clinical outcomes, ALS drug registration, ALS medication Saudi Arabia, ALS treatment, amyotrophic lateral sclerosis, antisense therapy, clinical trials, Health Sector Transformation Program, innovative therapies, Kingdom healthcare development, nerve cell protection, neurodegenerative disease, neurofilament reduction, orphan drugs, patient access, pharmaceutical innovation, protein misfolding therapy, Qalsody approval, rare disease therapy, rare genetic disease treatment, Saudi Arabia healthcare, Saudi FDA, Saudi medical innovation, Saudi patient care, Saudi rare disease patients, SOD1 gene, SOD1 protein reduction., Tofersen, vision 2030

Saudi FDA Approves Qalsody for ALS, Pioneering New Hope for Rare Disease Patients

Riyadh – In a landmark decision for rare disease treatment in Saudi Arabia, the Saudi Food and Drug Authority (SFDA)